Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
29
CCRN Quote, Financials, Valuation and Earnings
Last price:
$7.95
Seasonality move
:
-6.36%
Day range:
$7.89 - $8.05
52-week range:
$7.43 - $18.30
Dividend yield:
0%
P/E ratio:
64.87x
P/S ratio:
0.23x
P/B ratio:
0.64x
Volume:
993.6K
Avg. volume:
1.2M
1-year change:
-55.64%
Market cap:
$260.4M
Revenue:
$1.3B
EPS (TTM):
-$0.48
Analysts' Opinion
-
Consensus RatingCross Country Healthcare, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.66, Cross Country Healthcare, Inc. has an estimated upside of 21.54% from its current price of $7.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.65 representing 100% downside risk from its current price of $7.95.
Fair Value
-
According to the consensus of 7 analysts, Cross Country Healthcare, Inc. has 21.54% upside to fair value with a price target of $9.66 per share.
CCRN vs. S&P 500
-
Over the past 5 trading days, Cross Country Healthcare, Inc. has underperformed the S&P 500 by -6.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cross Country Healthcare, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cross Country Healthcare, Inc. revenues have been falling on a year-over-year basis for 12 quarters in a row. In the most recent quarter Cross Country Healthcare, Inc. reported revenues of $250.1M.
Earnings Growth
-
Cross Country Healthcare, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cross Country Healthcare, Inc. reported earnings per share of -$0.15.
Enterprise value:
163.5M
EV / Invested capital:
0.40x
Price / LTM sales:
0.23x
EV / EBIT:
25.94x
EV / Revenue:
0.15x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
3.58x
Price / Operating cash flow:
5.64x
Enterprise value / EBITDA:
6.93x
Gross Profit (TTM):
$210.3M
Return On Assets:
-2.75%
Net Income Margin (TTM):
-1.39%
Return On Equity:
-3.76%
Return On Invested Capital:
-3.74%
Operating Margin:
0.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.2B | $1.4B | $1.1B | $315.1M | $250.1M | |
| Gross Profit | $481.8M | $284.4M | $210.3M | $59.7M | $46.8M | |
| Operating Income | $154.5M | $13.2M | $6.3M | $3.9M | $806K | |
| EBITDA | $172.5M | $31.6M | $23.6M | $8.3M | $4.9M | |
| Diluted EPS | $2.82 | -$0.06 | -$0.48 | $0.08 | -$0.15 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $313.3M | $660M | $445.2M | $336.6M | $295.1M | |
| Total Assets | $520.4M | $882.5M | $707.7M | $597.4M | $538.2M | |
| Current Liabilities | $144.7M | $276.8M | $183.6M | $120.7M | $85.5M | |
| Total Liabilities | $303.6M | $459.8M | $238.1M | $172.7M | $130.1M | |
| Total Equity | $216.8M | $422.7M | $469.7M | $424.7M | $408.1M | |
| Total Debt | $118.7M | $135.2M | $3M | $2.3M | $1.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $240.7M | $108M | $54.2M | $7.5M | $20.1M | |
| Cash From Investing | -$48M | -$9.1M | -$8.6M | -$1.1M | -$2.2M | |
| Cash From Financing | -$208.8M | -$49.2M | -$10.6M | -$11.9M | -$6K | |
| Free Cash Flow | $227.6M | $98.9M | $45.7M | $6.3M | $17.9M | |
CCRN
Sector
Market Cap
$260.4M
$27.9M
Price % of 52-Week High
43.44%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
1.06%
-1.49%
1-Year Price Total Return
-55.64%
-16.66%
Beta (5-Year)
0.422
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.21
200-day SMA
Sell
Level
$13.00
Bollinger Bands (100)
Sell
Level
10.39 - 13.93
Chaikin Money Flow
Sell
Level
-2.4M
20-day SMA
Sell
Level
$9.05
Relative Strength Index (RSI14)
Sell
Level
30.66
ADX Line
Sell
Level
39.18
Williams %R
Buy
Level
-82.3729
50-day SMA
Sell
Level
$11.02
MACD (12, 26)
Sell
Level
-0.94
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-12.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.3082)
Buy
CA Score
(Annual)
Level (1.2846)
Buy
Beneish M-Score
(Annual)
Level (-3.8146)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-3.9738)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the Nurse and Allied Staffing and Physician Staffing segments. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing. The Physician Staffing segment includes certified registered nurse anesthetists, nurse practitioners, and physician assistants. The company was founded by Kevin C. Clark in 1986 and is headquartered in Boca Raton, FL.
Stock Forecast FAQ
In the current month, CCRN has received 0 Buy ratings 7 Hold ratings, and 0 Sell ratings. The CCRN average analyst price target in the past 3 months is $9.66.
-
Where Will Cross Country Healthcare, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cross Country Healthcare, Inc. share price will rise to $9.66 per share over the next 12 months.
-
What Do Analysts Say About Cross Country Healthcare, Inc.?
Analysts are divided on their view about Cross Country Healthcare, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cross Country Healthcare, Inc. is a Sell and believe this share price will drop from its current level to $8.65.
-
What Is Cross Country Healthcare, Inc.'s Price Target?
The price target for Cross Country Healthcare, Inc. over the next 1-year time period is forecast to be $9.66 according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CCRN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cross Country Healthcare, Inc. is a Hold. 7 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CCRN?
You can purchase shares of Cross Country Healthcare, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cross Country Healthcare, Inc. shares.
-
What Is The Cross Country Healthcare, Inc. Share Price Today?
Cross Country Healthcare, Inc. was last trading at $7.95 per share. This represents the most recent stock quote for Cross Country Healthcare, Inc.. Yesterday, Cross Country Healthcare, Inc. closed at $7.95 per share.
-
How To Buy Cross Country Healthcare, Inc. Stock Online?
In order to purchase Cross Country Healthcare, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CCRN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CCRN
Sector
P/E ratio
64.87x
23.85x
PEG ratio
-0.02x
-0.01x
P/B ratio
0.64x
1.81x
Price / LTM sales
0.23x
1.58x
Growth Metrics
CCRN
Sector
Revenue growth
-20.65%
4.62%
Earnings growth
-289.91%
10.5%
Revenue (5-year growth)
10.33%
6.5%
Earnings forecast
$0.04
-$0.21
Profitability
CCRN
Sector
Profitability FY 2024
$256.1M
$3.6M
Return on invested capital
-3.74%
-31.87%
Return on assets
-2.75%
-28.18%
Return on equity
-3.76%
-37.63%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
11
Balance Sheet
CCRN
Sector
Total cash
$99.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$589.3M
$76.9M
Long term debt
$1.4M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
